← Leaderboards
Gregory J Kato
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaNitric OxideHuman SubjectDrug Screening /EvaluationPlethysmographyAtorvastatinInflammationProteomicsGene ExpressionPhysiologicalAdverse EffectsOmega-N-MethylarginineBiological AvailabilityOxidationPlasmaHuman Therapy EvaluationAfrican AmericanInfusion ProceduresForearmHemoglobinEnrollmentCellsFunctional DisorderBlood Flow
Grant awards (8)
Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease$0
Z01 · FY2008 · CL · contact PI
Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease$0
Z01 · FY2008 · CL · contact PI
Atorvastatin Therapy to Improve Endothelial Function in$0
Z01 · FY2006 · CL · contact PI
Therapeutic Application of Intravascular Nitrite for Sic$0
Z01 · FY2006 · CL · contact PI
Atorvastatin Therapy to Improve Endothelial Function in$0
Z01 · FY2005 · CL
Therapeutic Application of Intravascular Nitrite for SCD$0
Z01 · FY2005 · CL
Atorvastatin Endothelial Function in Sickle Cell Disease$0
Z01 · FY2004 · CL
Atorvastatin Therapy and Endothelial Function in SCD$0
Z01 · FY2003 · CL